NALOXONE HYDROCHLORIDE INJECTION SDZ PRESERVATIVE FREE 0.4 MG
NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE) : 0.4 MG · DIN 02382601 · SANDOZ CANADA INCORPORATED
Health Canada status: CANCELLED POST MARKET
What is NALOXONE HYDROCHLORIDE INJECTION SDZ PRESERVATIVE FREE?
NALOXONE HYDROCHLORIDE INJECTION SDZ PRESERVATIVE FREE 0.4 MG contains NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE) : 0.4 MG. It is listed in the Health Canada Drug Product Database under DIN 02382601, held by SANDOZ CANADA INCORPORATED, supplied as SOLUTION for SUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 01-Aug-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02382601 |
|---|---|
| Brand name | NALOXONE HYDROCHLORIDE INJECTION SDZ PRESERVATIVE FREE |
| Generic / active ingredient | NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE DIHYDRATE) : 0.4 MG |
| Manufacturer | SANDOZ CANADA INCORPORATED |
| Strength | 0.4 MG |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | V03AB15 NALOXONE |
| AHFS class | 40:28.20 ; 24:32.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 01-Aug-2019 |
| Original market date | 2012-04-02 00:00:00 |
Is NALOXONE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for NALOXONE HYDROCHLORIDE INJECTION SDZ PRESERVATIVE FREE
What can be used instead?
Other Canadian products sharing ATC code V03AB15 NALOXONE. 12 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| INJECTABLE NALOXONE HYDROCHLORIDE | 0.4 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02455935 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02148706 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02148714 |
| NALOXONE HYDROCHLORIDE INJECTION | 0.4 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02393034 |
| NALOXONE HYDROCHLORIDE INJECTION | 1 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02393042 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02382482 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4 MG | SOLUTION | STERINOVA INC. | MARKETED | DIN 02548194 |
| NALOXONE HYDROCHLORIDE INJECTION, USP | 4 MG / 10 ML | SOLUTION | EUGIA PHARMA INC. | MARKETED | DIN 02534975 |
| NALOXONE INJECTABLE | 0.4 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02458578 |
| NARCAN NASAL SPRAY | 4 MG / 0.1 ML | SPRAY, METERED DOSE | EMERGENT OPERATIONS IRELAND LIMITED | MARKETED | DIN 02458187 |
Who else supplies NALOXONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NALOXONE appears in 47 registered pack listings across 9 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.